Bioxcel Therapeutics Stock Price History
| BTAI Stock | USD 1.43 0.16 10.06% |
Below is the normalized historical share price chart for BioXcel Therapeutics extending back to March 08, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of BioXcel Therapeutics stands at 1.43, as last reported on the 31st of July, with the highest price reaching 1.59 and the lowest price hitting 1.39 during the day.
If you're considering investing in BioXcel Stock, it is important to understand the factors that can impact its price. BioXcel Therapeutics secures Sharpe Ratio (or Efficiency) of -0.026, which signifies that the company had a -0.026 % return per unit of risk over the last 3 months. BioXcel Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BioXcel Therapeutics' Risk Adjusted Performance of 0.0023, mean deviation of 4.33, and Standard Deviation of 6.09 to double-check the risk estimate we provide. As of now, BioXcel Therapeutics' Common Stock is increasing as compared to previous years. The BioXcel Therapeutics' current Stock Based Compensation is estimated to increase to about 10.3 M, while Total Stockholder Equity is forecasted to increase to (88.4 M). . The current Price To Sales Ratio is estimated to decrease to 6.36. The current Price Earnings Ratio is estimated to decrease to -0.27. BioXcel Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of March 2018 | 200 Day MA 4.2287 | 50 Day MA 1.7128 | Beta 0.043 |
Sharpe Ratio = -0.026
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BTAI |
Estimated Market Risk
| 6.35 actual daily | 56 56% of assets are less volatile |
Expected Return
| -0.17 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average BioXcel Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioXcel Therapeutics by adding BioXcel Therapeutics to a well-diversified portfolio.
Price Book 3.9656 | Enterprise Value Ebitda (0.75) | Price Sales 5.1993 | Shares Float 5.5 M | Wall Street Target Price 19 |
BioXcel Therapeutics Stock Price History Chart
There are several ways to analyze BioXcel Stock price data. The simplest method is using a basic BioXcel candlestick price chart, which shows BioXcel Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | June 25, 2025 | 2.05 |
| Lowest Price | May 30, 2025 | 1.18 |
BioXcel Therapeutics July 31, 2025 Stock Price Synopsis
Various analyses of BioXcel Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell BioXcel Stock. It can be used to describe the percentage change in the price of BioXcel Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of BioXcel Stock.| BioXcel Therapeutics Accumulation Distribution | 48,955 | |
| BioXcel Therapeutics Price Rate Of Daily Change | 0.90 | |
| BioXcel Therapeutics Price Action Indicator | (0.14) | |
| BioXcel Therapeutics Price Daily Balance Of Power | (0.80) |
BioXcel Therapeutics July 31, 2025 Stock Price Analysis
BioXcel Stock Price History Data
The price series of BioXcel Therapeutics for the period between Fri, May 2, 2025 and Thu, Jul 31, 2025 has a statistical range of 0.87 with a coefficient of variation of 13.9. The prices are distributed with arithmetic mean of 1.7. The median price for the last 90 days is 1.77. The company had 1:16 stock split on 10th of February 2025.| Open | High | Low | Close | Volume | ||
07/30/2025 | 1.57 | 1.59 | 1.39 | 1.43 | 389,190 | |
07/29/2025 | 1.73 | 1.76 | 1.57 | 1.59 | 283,701 | |
| 07/28/2025 | 1.80 | 1.82 | 1.65 | 1.70 | 356,948 | |
07/25/2025 | 1.78 | 1.83 | 1.75 | 1.81 | 213,868 | |
| 07/24/2025 | 1.77 | 1.80 | 1.70 | 1.73 | 334,500 | |
07/23/2025 | 1.81 | 1.87 | 1.75 | 1.81 | 372,129 | |
| 07/22/2025 | 1.92 | 1.92 | 1.74 | 1.81 | 384,386 | |
| 07/21/2025 | 1.94 | 1.95 | 1.88 | 1.89 | 264,675 | |
| 07/18/2025 | 1.94 | 2.00 | 1.87 | 1.91 | 176,305 | |
07/17/2025 | 1.94 | 1.98 | 1.87 | 1.94 | 281,495 | |
07/16/2025 | 1.91 | 2.01 | 1.86 | 1.95 | 289,011 | |
| 07/15/2025 | 2.20 | 2.27 | 1.88 | 1.90 | 1,409,729 | |
07/14/2025 | 1.98 | 2.07 | 1.90 | 2.02 | 274,727 | |
07/11/2025 | 2.00 | 2.06 | 1.91 | 1.97 | 140,548 | |
07/10/2025 | 2.00 | 2.15 | 1.99 | 2.00 | 301,124 | |
07/09/2025 | 2.00 | 2.10 | 1.96 | 2.00 | 297,873 | |
07/08/2025 | 1.88 | 2.03 | 1.81 | 2.01 | 294,204 | |
07/07/2025 | 1.97 | 2.00 | 1.83 | 1.90 | 264,248 | |
| 07/03/2025 | 1.98 | 1.98 | 1.92 | 1.93 | 78,653 | |
07/02/2025 | 1.99 | 2.00 | 1.88 | 1.93 | 222,160 | |
| 07/01/2025 | 1.91 | 2.00 | 1.86 | 1.97 | 281,579 | |
| 06/30/2025 | 1.79 | 1.85 | 1.69 | 1.81 | 173,268 | |
06/27/2025 | 2.08 | 2.08 | 1.75 | 1.77 | 450,539 | |
06/26/2025 | 2.00 | 2.03 | 1.83 | 2.03 | 1,161,991 | |
| 06/25/2025 | 1.93 | 2.22 | 1.81 | 2.05 | 1,298,249 | |
06/24/2025 | 1.78 | 1.83 | 1.63 | 1.73 | 78,561 | |
| 06/23/2025 | 1.61 | 1.72 | 1.59 | 1.65 | 151,366 | |
06/20/2025 | 1.78 | 1.88 | 1.60 | 1.60 | 138,930 | |
| 06/18/2025 | 1.64 | 1.80 | 1.64 | 1.73 | 97,761 | |
06/17/2025 | 1.68 | 1.73 | 1.61 | 1.64 | 53,969 | |
| 06/16/2025 | 1.50 | 1.72 | 1.46 | 1.69 | 118,555 | |
| 06/13/2025 | 1.70 | 1.70 | 1.53 | 1.56 | 193,573 | |
06/12/2025 | 1.76 | 1.80 | 1.71 | 1.77 | 37,464 | |
06/11/2025 | 2.03 | 2.03 | 1.76 | 1.79 | 218,516 | |
06/10/2025 | 1.99 | 2.11 | 1.96 | 1.99 | 267,768 | |
06/09/2025 | 1.85 | 2.01 | 1.85 | 1.96 | 287,241 | |
06/06/2025 | 1.56 | 1.84 | 1.55 | 1.84 | 281,946 | |
06/05/2025 | 1.54 | 1.58 | 1.44 | 1.53 | 162,286 | |
06/04/2025 | 1.39 | 1.53 | 1.36 | 1.53 | 200,599 | |
06/03/2025 | 1.33 | 1.44 | 1.31 | 1.37 | 226,171 | |
06/02/2025 | 1.19 | 1.37 | 1.18 | 1.32 | 274,060 | |
| 05/30/2025 | 1.20 | 1.21 | 1.17 | 1.18 | 162,013 | |
05/29/2025 | 1.26 | 1.31 | 1.21 | 1.23 | 207,514 | |
05/28/2025 | 1.39 | 1.39 | 1.25 | 1.26 | 414,437 | |
| 05/27/2025 | 1.42 | 1.42 | 1.30 | 1.39 | 5,427,697 | |
05/23/2025 | 1.36 | 1.42 | 1.30 | 1.39 | 105,588 | |
05/22/2025 | 1.41 | 1.43 | 1.34 | 1.37 | 130,825 | |
05/21/2025 | 1.40 | 1.48 | 1.36 | 1.39 | 92,412 | |
05/20/2025 | 1.45 | 1.45 | 1.40 | 1.42 | 79,759 | |
05/19/2025 | 1.43 | 1.47 | 1.39 | 1.44 | 96,184 | |
05/16/2025 | 1.45 | 1.51 | 1.42 | 1.45 | 97,044 | |
05/15/2025 | 1.39 | 1.50 | 1.35 | 1.46 | 185,970 | |
05/14/2025 | 1.43 | 1.47 | 1.34 | 1.37 | 156,010 | |
05/13/2025 | 1.48 | 1.51 | 1.35 | 1.43 | 229,750 | |
05/12/2025 | 1.59 | 1.59 | 1.43 | 1.48 | 153,549 | |
05/09/2025 | 1.60 | 1.64 | 1.50 | 1.53 | 72,940 | |
05/08/2025 | 1.52 | 1.60 | 1.50 | 1.58 | 82,633 | |
05/07/2025 | 1.57 | 1.61 | 1.50 | 1.53 | 69,334 | |
05/06/2025 | 1.71 | 1.75 | 1.56 | 1.58 | 117,400 | |
05/05/2025 | 1.79 | 1.82 | 1.67 | 1.71 | 82,154 | |
05/02/2025 | 1.84 | 1.89 | 1.74 | 1.78 | 83,164 |
About BioXcel Therapeutics Stock history
BioXcel Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BioXcel is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BioXcel Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BioXcel Therapeutics stock prices may prove useful in developing a viable investing in BioXcel Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 2.5 M | 2.4 M | |
| Net Loss | -149.2 M | -141.7 M |
BioXcel Therapeutics Quarterly Net Working Capital |
|
BioXcel Therapeutics Stock Technical Analysis
BioXcel Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
| All Next | Launch Module |
BioXcel Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for BioXcel Therapeutics' price direction in advance. Along with the technical and fundamental analysis of BioXcel Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BioXcel to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0023 | |||
| Jensen Alpha | (0.39) | |||
| Total Risk Alpha | (1.30) | |||
| Treynor Ratio | (0.03) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for BioXcel Stock analysis
When running BioXcel Therapeutics' price analysis, check to measure BioXcel Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioXcel Therapeutics is operating at the current time. Most of BioXcel Therapeutics' value examination focuses on studying past and present price action to predict the probability of BioXcel Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioXcel Therapeutics' price. Additionally, you may evaluate how the addition of BioXcel Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |